Majority of healthcare authorities believe that due to the methodological weakness and small number of patients in conducted therapeutic trials, the evidences are insufficient to support the efficacy of intravenous immunoglobulin (IVIG) in prevention of preterm neonatal sepsis. The objective of this research is to determine the effect of intravenous immunoglobulin in prevention of preterm neonatal sepsis.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Enrollment
92
IVIG at a dose of 500mg/kg within 12 h and 3 days of birth
Shahid Mohammadi hospital
Bandar Abbas, Hormozgan, Iran
Mortality
Death from sepsis or its related complications
Time frame: 7 days
Total number of days of hospitalization
Duration of hospitalization
Time frame: 7 days
Intraventricular Hemorrhage
occurrence of Intraventricular Hemorrhage
Time frame: 7 days
Necrotizing enterocolitis
occurrence of Necrotizing enterocolitis
Time frame: 7 days
Bronchopulmonary dysplasia
occurrence of Bronchopulmonary dysplasia
Time frame: 7 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.